ClinicalTrials.gg
CompletedNCT00898885ORALGVHDUpdated May 12, 2009

Analysis of the Clinical and Histological Correlation of Oral Graft-Versus-Host-Disease (GVHD)

An observational study in Graft-Versus-Host Disease, sponsored by University of Sao Paulo. Completed. Per ClinicalTrials.gov, last updated 2009-05-12.

Sponsored by University of Sao Paulo · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
41
Sex
All
01

Study summary

Introduction: Graft-versus-host-disease (GVHD) is the major cause of morbidity and mortality in patients submitted to the Bone Marrow Transplantation (BMT). The oral manifestations can be very debilitating and interfere in the results of medical therapy, leading to systemic complications, committing the prognosis and quality of life of the patient.

The early diagnosis can be done through biopsies of oral mucosa with or without apparent injury clinic. The association between the clinical and histopathological tables of GVHD, especially through the use of recent consensus established in these areas, can bring new benefits to physicians.

Objective: This study aims to apply and compare the two classifications histological to GVHD, Horn (1995) and Consensus (2006) in specimens obtained from clinical oral lesions suggestive of GVHD; correlate them with clinical classification according Akpek (2001) and with the survival of the patients.

Read the detailed description

Methods: For this study we analyzed histological samples of oral mucosa of 10 patients with clinical diagnosis of GVHD, which have areas of epithelium, and salivary gland. The histopathological aspects were observed by the author of this work and his advisor, so blinded by applying the criteria for Horn and the Consensus. We consistency between the two classifications obtained and histological correlation with the clinical classification of GVHD (Akpek, 2001) and the curve of survival.

02

Conditions studied

  • Graft-Versus-Host Disease

Keywords

  • oral manifestations
  • bone marrow transplantation
  • adverse effects
03

In context

Graft vs Host Disease

815 studies on the registry are indexed under Graft vs Host Disease; 138 are open to participants now.

This study's enrollment of 41 is below the median of 82 across 104 observational studies indexed under Graft vs Host Disease.

Browse Graft vs Host Disease studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,030 studies on the registry; 92 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients underwent bone marrow transplantation with clinical signs of oral Graft-versus-host Disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all patients with clinical signs of oral GVHD that underwent oral biopsy

Exclusion criteria

Exclusion Criteria:

  • samples without epithelium or minor salivary glands
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
41 participants (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • Bone Marrow Transplantation

    Procedure: oral biopsy

Interventions

  • Procedureoral biopsy

    oral mucosa and salivary gland biopsy after bone marrow transplantation

    Also known as: oral manifestations, graft-versus-host disease, bone marrow transplantation

06

What researchers measure

Primary outcomes

  1. The histological classification according Horn showed that in most cases there was presence of GVHD with low degrees of severity; Already classification of the Consensus showed that there were in full presence of GVHD of moderate degree.

    Time frame: during the survey data, and analysis of specimens

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2008, a primary completion of Oct 2008 and a completion of Apr 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 11, 2009
First posted
May 12, 2009
Start
Jan 2008
Primary completionActual
Oct 2008
CompletionActual
Apr 2009
Last update
May 12, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00898885
First posted
May 12, 2009
Start date
Jan 2008
Primary completion
Oct 2008
Completion
Apr 2009
Last update
May 12, 2009

Study contacts

Marina HG Magalhães, DMD, PhD
study chair · University of Sao Paulo - Brazil

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion